|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.08 CNY | +2.44% |
|
+5.12% | +2.61% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.7 | +36.62% | 7 | ||||||
| 61.48 | +93.64% | 16 | ||||||
| 4.639 | +59.93% | 15 | ||||||
| 2,979 | +22.24% | 10 | ||||||
| 33.22 | +60.46% | 12 | ||||||
| 338.5 | +54.38% | 8 | ||||||
| 125.87 | +36.67% | 9 | ||||||
| 47 | +16.65% | 6 | ||||||
| - | - | 1,415 | +214.44% | 1 | ||||
| 37.19 | +14.04% | 8 | ||||||
| 79.67 | +20.89% | 9 | ||||||
| 1,168.71 | +42.22% | 7 | ||||||
| 56.82 | +33.39% | 8 | ||||||
| 14.86 | +43.04% | 5 | ||||||
| - | 90 | +19.52% | 2 | |||||
| - | 5,100 | +33.86% | 2 | |||||
| Average | 723.54 | +50.12% | 8 | ||||||
| Weighted average by Cap. | 542.26 | +62.63% | 11 |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
